Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 8,297.0 | 7,442.0 | 6,699.0 | 6,258.0 | 6,063.0 | 8,535.0 | 5,313.0 | 5,051.0 |
| Revenue growth | 11.5% | 11.1% | 7.0% | 3.2% | -29.0% | 60.6% | 5.2% | 7.4% |
| Cost of goods sold | 2,195.0 | 2,094.0 | 1,976.0 | 1,838.0 | 1,694.0 | 1,773.0 | 1,718.0 | 1,651.0 |
| Gross profit | 6,102.0 | 5,348.0 | 4,723.0 | 4,420.0 | 4,369.0 | 6,762.0 | 3,595.0 | 3,400.0 |
| Gross margin | 73.5% | 71.9% | 70.5% | 70.6% | 72.1% | 79.2% | 67.7% | 67.3% |
| Selling, general and administrative | 1,714.0 | 1,541.0 | 1,342.0 | 1,424.0 | 1,606.0 | 1,467.0 | 1,532.0 | 3,144.0 |
| EBITA | 4,306.0 | 3,724.0 | 3,299.0 | 2,912.0 | 2,681.0 | 3,437.0 | 1,984.0 | 161.0 |
| EBITA margin | 51.9% | 50.0% | 49.2% | 46.5% | 44.2% | 40.3% | 37.3% | 3.2% |
| Amortization of intangibles | 96.0 | 123.0 | 122.0 | 122.0 | 98.0 | 96.0 | 67.0 | 48.0 |
| EBIT | 4,210.0 | 3,601.0 | 3,177.0 | 2,790.0 | 2,583.0 | 3,341.0 | 1,917.0 | 113.0 |
| EBIT margin | 50.7% | 48.4% | 47.4% | 44.6% | 42.6% | 39.1% | 36.1% | 2.2% |
| Pre-tax income | 4,164.0 | 3,228.0 | 2,930.0 | 2,681.0 | 2,461.0 | 3,188.0 | 1,815.0 | 54.0 |
| Income taxes | 901.0 | 694.0 | 627.0 | 560.0 | 823.0 | 960.0 | 547.0 | 245.0 |
| Tax rate | 21.6% | 21.5% | 21.4% | 20.9% | 33.4% | 30.1% | 30.1% | 453.7% |
| Earnings from continuing ops | 3,263.0 | 2,534.0 | 2,303.0 | 2,121.0 | 1,638.0 | 2,228.0 | 1,268.0 | -382.0 |
| Earnings from discontinued ops | | | | | | | | 178.0 |
| Net income | 3,263.0 | 2,534.0 | 2,303.0 | 2,121.0 | 1,638.0 | 2,228.0 | 1,268.0 | -204.0 |
| Net margin | 39.3% | 34.0% | 34.4% | 33.9% | 27.0% | 26.1% | 23.9% | -4.0% |
| |
| Diluted EPS | $13.49 | $10.47 | $9.33 | $8.38 | $6.33 | $8.40 | $4.62 | ($1.41) |
| Shares outstanding (diluted) | 241.8 | 242.1 | 246.9 | 253.2 | 258.9 | 265.2 | 274.6 | 271.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|